TSX:ACBPharmaceuticals
Aurora Cannabis (TSX:ACB): Revenue Forecasted to Outpace Market as Losses Narrow Ahead of Earnings
Aurora Cannabis (TSX:ACB) remains unprofitable, but the company has reduced its losses at an impressive annual rate of 61.2% over the past five years. The stock trades at a Price-to-Sales ratio of 1x, below its peer average of 2.1x, and sits well below an estimated fair value of CA$23.27 with a current share price of CA$6.29. With revenue expected to grow 6.49% per year, outpacing the broader Canadian market, investors may see the trend of narrowing losses and steady forecasted growth as...